Our Opinion

InMed Pharmaceuticals Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following article that they exploit animals for product testing.

“Of note, the company recently disclosed in vivo animal data for INM-088 at the H.C. Wainwright Ophthalmology Virtual Conference, which indicated a significant lowering of intraocular pressure (IOP) at days 7 and 17 compared to the vehicle treated group.” Read the following article

Company Description

InMed Pharmaceuticals Inc. is a clinical stage pharmaceutical company that is engaged in the development, manufacturing and commercialization of rare cannabinoids. The Company is developing a pipeline of prescription-based products targeting treatments for diseases with unmet medical needs as well as developing manufacturing technologies.

Company Website: https://www.inmedpharma.com